Top 10 Medical Angel Investors in Switzerland in October 2023
Top 10 Medical Angel Investors in Switzerland in October 2023
| Investor | Medical Switzerland investments |
|---|---|
| Penny Schiffer | 2 |
| Willi Miesch | 1 |
| Arda Kara | 1 |
| Rajat Khare | 1 |
| Walter Fischl | 1 |
| Adrian Bult | 1 |
| Justin Mateen | 1 |
| Jacques R. Seguin | 1 |
| Vic Lee | 1 |
| Karl Landert | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Health Care, Medical, Finance
- Funding Round, Seed, Series A
- Switzerland, Germany, United Kingdom
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Willi Miesch is an experienced entrepreneur with focus on the MedTech segment. Since 1998 he is CEO of Medartis managing the complete operative business. He is additionally member of the Board of Medartis as well as member of the Board of the International Bone Research Association (IBRA). Before joining Medartis, he worked in various productiondepartments of Stratec Medical (Ticino), the Institut Straumann AG (Switzerland and USA). Moreover, he was a member of the Board of Management of a bicycle manufacturer being responsible for the entire technical part for several years. Willi Miesch started as a precision engineer and extended his qualifications by finishing his degree as an operations technician TS at the ABB Engineering School Baden. He completed his postgraduate studies in market-oriented Business Management at the University of Central Switzerland.
Show more...Investment focus
- Medical, Health Care, Personal Health
- Series A
- Switzerland
Portfolio highlights
- Scewo — Scewo is a medical technology platform that develops stair-climbing wheelchair. Founded in 2017, the company is headquartered in Winterthur, Zurich, Switzerland.
Arda Kara
Show more...Investment focus
- Health Care, Medical, Software
- Series A, Seed, Series B
- United States, Germany, Switzerland
Portfolio highlights
- Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
- Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
- Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
An Internet-age investor and a serial entrepreneur, Rajat Khare is the founder of the European (luxembourg based) investment firm -Boundary Holding. A prominent investment fund with presence in France and Luxembourg, Boundary Holding invests globally in spaces related to Artificial Intelligence (AI) and allied fields such as Data Analytics andMining, Machine learning and Predictive Analytics.Boundary Holding primarily acts as a Bridge fund for startups and organizations, facilitating funds across Safe cities, Internet of Things, Algorithmic trading, AI and Analytics. The company has a network of startup programs around the world.Rajat khare holds a Computer Science degree from IIT-Delhi, and has interned at RUCA, University of Antwerp in the Department of Mathematics. He has been a keynote speaker in over 20 major conferences and events across the globe. His work as an investor has also been cited as a case study in the course of Entrepreneurship run by Professor Patrick Turner in INSEAD Business School. He has authored various research papers published in international conferences and books, such as Data Mining V by WIT press. Rajat has co-authored Make the Move on entrepreneurship and Science of Achievement on education. Both the books reflect Rajat’s inclination towards promoting entrepreneurship and a holistic incubation of innovative solutions around the world.An active member of The Indus Entrepreneurs (TIE), the IIT Delhi alumni association and the Indian angel network, Rajat proactively supports and encourages entrepreneurs and entrepreneurial ventures around the world. For his efforts to promote entrepreneurship, he was appreciated by Dr APJ Abdul Kalam at the President’s house in 2006.
Show more...Investment focus
- Drones, Aerospace, Artificial Intelligence
- Series A, Series B, Funding Round
- France, Switzerland, Germany
Portfolio highlights
- CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
- Scewo — Scewo is a medical technology platform that develops stair-climbing wheelchair. Founded in 2017, the company is headquartered in Winterthur, Zurich, Switzerland.
- EdallSystems — EdallSystems provide Educational Service (Aerospace Engineering Training), UAV development, Engineering Service(Lab Development) and consulting in INDIA. Their moto is to become a major Product Development company in the filed of Aerospace In India and to support and Develope Aerospace products in India.
Walter Fischl
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Switzerland
Portfolio highlights
- ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Adrian Bult studied business administration and marketing at the University of St. Gallen (lic. oec. HSG). From 1984 to 1997 he held several national and international sales positions with IBM and served as a member of the Executive Board of IBM Switzerland. Until 1998 he was Head of Information Technology at Telecom PTT, after which he joined theGroup Executive Board of Swisscom, first as CIO, then as CEO of Swisscom Fixnet and finally as CEO of Swisscom Mobile.From 2007 to 2012 Adrian R. Bult was a member of the Executive Board and also a shareholder of COO Avaloq Evolution AG. He is Chairman of the Board of Directors of Swissgrid AG and also sits on the boards of directors of several other companies, including Swissquote AG and Regent Beleuchtungskörper AG. Adrian R. Bult is married and has one daughter.
Show more...Investment focus
- Video, Mobile, Medical
- Seed, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Mila — Mila is all about providing access to progress. The world around us is moving fast. Technical and digital innovations appear daily. There’s no way they can all keep up with this development. Perhaps you don’t have time or you’re just not up to a technical challenge. Still, everyone should be able to benefit from technological progress. Mila enablespeople to find an expert partner in their neighborhood on demand. Conveniently and easily, at a fair price.
- LaterPay — LaterPay simplifies payments on the Internet. In addition to a classic immediate purchase option, LaterPay also allows you to buy digital content such as articles now and pay later.LaterPay allows you to purchase digital content for even the smallest amounts without having to pay directly. You simply confirm that you want to pay later and thenyou can access the content you want. You don't have to register or provide payment details beforehand. LaterPay remembers all the purchases you make on your device and bundles them into one invoice. No matter which website LaterPay uses, you simply shop - and all purchases appear together on one LaterPay invoice. As soon as your tab reaches $5.00, we ask you to register. Afterwards you choose your preferred payment method. There are no fees for you; you only pay for what you actually buy.
- Medical Insights — Medical Insight's mission is to create an open medical community platform which serves Health Care Professionals (HCP) of various specialties, international medical foundations and its medical industry partners with targeted personalized knowledge, education and communication services.
Justin Mateen is the Founder of Tinder, the world's largest dating platform. Founded in 2012, Tinder is the highest grossing app on Apple's app store since 2017 and was valued at over $40 Billion dollars in 2021. In 2021, Business Insider ranked Mateen as the best early stage investor in the US, placing him at the number 1 spot on thetop 100 list of US Seed Investors. In 2020, Forbes included Mateen on their list of the decade's top 10 tech entrepreneurs. Fast Company has listed him as one of the most creative people in business.
Show more...Investment focus
- Software, E-Commerce, Financial Services
- Seed, Series A, Pre-Seed
- United States, Mexico, India
Portfolio highlights
- Whop — One-stop-shop for all the latest and greatest digital products to help you earn online. From trading software to reselling communities, we've got you.
- Slash — Tens of thousands of online businesses use Slash to track their profits, earn cash back, and get faster payouts from platforms like GOAT and Amazon. No LLC required, no account fees, no minimum balance, and no credit checks.
- Somethings — We connect your teen with a professional, trained 20-28 year old mentor who supports your teen via text and video call whenever they need. Start today.
Jacques Seguin is the Chairman Of The Board at Emanate Biomedical.
Show more...Investment focus
- Medical, Medical Device, Health Care
- Seed, Funding Round
- Israel, Switzerland
Portfolio highlights
- Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Vic Lee is the founder and managing partner of Virtus Inspire. Vic is one of the founders and former senior executive vice president of Tencent, the largest Internet company in China with a market value of about USD 200 billion. He joined Tencent in 1999 and was responsible for planning, construction and managing the operation platforms, includingtechnical architecture, information security, payment settlements, business intelligence, sales channel connection, fundamental IT, applications maintenance and customer services. From 2010 to 2012, Vic was in charge of the Company’s online search businesses. After leaving Tencent in 2012, he began to invest in technology companies in US, Israel and China. Vic was recognised as the "China Top Chief Information Officer" by 'CEO & CIO China' magazine in 2010.
Show more...Investment focus
- Apps, Mobile, Medical
- Seed
- Switzerland, United States
Portfolio highlights
- Yo — Yo is a simple and efficient single-tap zero character communication tool.
- Aeris Health — aeris is the first provider of full indoor air quality treatment systems. We provide a unique air purifier product line capable of tackling any type of air pollution at home or at work. Unlike current static air treatment products, our system constantly tracks indoor air quality and room occupancy, to ensure our air purification and ventilationdevices ensure best air quality with lowest energy consumption.We continue to push boundaries on nano-spun filter technology, proprietary air quality sensor technology and sleek minimalist air purifier design. Our aeris fleet management software employs latest control system techniques to ensure lowest energy consumption of our products while keeping PM2.5, CO2 and VOC at lowest levels.
Karl is the CEO and investor in eClinicalHealth, as well as the Chairman of the Board and an advisor to Clinpal and key customers. Karl’s career started at IBM in 1985. He was the founder of the IBM ClinWare Solution Unit, one of the first EDC systems for clinical trials in the mid-nineties. Between 1998 and 2001 he worked at Novartis as ChiefInformation Officer. His career continued at Credit Suisse, where he assumed several senior leadership positions in IT. He became CIO of the Group in 2008 and was a Member of the Executive Board of Credit-Suisse until 2012. In his functions at Credit-Suisse he oversaw hundreds of global change programs. In 2012 and 2013 Karl advised the Chairman of Credit-Suisse in setting up an innovation program for the firm. After retiring from Credit-Suisse in March 2013 Karl focused on a portfolio of investments in start-up companies, continues to advise Senior Leaders and is a Non-Executive director in technology companies. As of November 2015 Karl has taken on the role of CEO and dedicates his energy to eClinicalHealth where he defines and manages the direction of the company.
Show more...Investment focus
- Medical, Health Care, Software
- Seed, Series B
- Switzerland, United Kingdom
Portfolio highlights
- Clinpal — eClinicalHealth are a technology and consulting company providing solutions for the clinical trials industry. The company has developed a technology solution called Clinpal: Clinpal is a patient-centric, cloud-enabled platform that improves patient engagement and data acquisition through every step of the clinical trial journey. Clinpal allowsclinical trials get closer to the patient, improving trial efficiency, patient retention and helps capture high quality data in real time. The platform features a comprehensive workflow and communication engine for all stakeholders, including sites, patients CRAs and sponsors, which improves efficiency through the trial lifecycle. Clinpal’s data exchange capabilities enable the platform to act as an intelligent data hub, consolidating and enhancing biometric data with eSource reported directly by patients or clinicians. The scalable cloud architecture, automated configuration and flexible licensing models make these capabilities a viable choice across a wide range of clinical trials.
- Medical Insights — Medical Insight's mission is to create an open medical community platform which serves Health Care Professionals (HCP) of various specialties, international medical foundations and its medical industry partners with targeted personalized knowledge, education and communication services.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: